These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31451965)

  • 1. Treatment Failure of Isavuconazole in a Patient with Cryptococcosis.
    Linder KA; Gandhi TN; Miceli MH
    Mycopathologia; 2019 Oct; 184(5):667-670. PubMed ID: 31451965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
    McCarthy MW; Moriyama B; Petraitiene R; Walsh TJ; Petraitis V
    Clin Pharmacokinet; 2018 Dec; 57(12):1483-1491. PubMed ID: 29725999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life use of isavuconazole outside the hematological wards.
    Scabini S; Lupia T; Angilletta R; De Rosa FG; Corcione S
    Eur J Intern Med; 2019 Dec; 70():e10-e12. PubMed ID: 31526649
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic drug concentrations of isavuconazole following the administration of isavuconazonium sulfate capsules via gastro-jejunum tube: A case report.
    Adamsick ML; Elshaboury RH; Gift T; Mansour MK; Kotton CN; Gandhi RG
    Transpl Infect Dis; 2019 Apr; 21(2):e13048. PubMed ID: 30636363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature.
    Pomorska A; Malecka A; Jaworski R; Radon-Proskura J; Hare RK; Nielsen HV; Andersen LO; Jensen HE; Arendrup MC; Irga-Jaworska N
    Mycopathologia; 2019 Feb; 184(1):81-88. PubMed ID: 30039238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.
    Perfect JR; Cornely OA; Heep M; Ostrosky-Zeichner L; Mullane KM; Maher R; Croos-Dabrera R; Lademacher C; Engelhardt M; Chen C; Marty FM
    Mycoses; 2018 Jul; 61(7):420-429. PubMed ID: 29570857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isavuconazole-induced Acute Liver Failure in a Pediatric Patient With Invasive Aspergillosis.
    Brivio E; Verna M; Migliorino GM; Foresti S; Zucchini N; Rovelli A
    Pediatr Infect Dis J; 2019 Oct; 38(10):1035-1037. PubMed ID: 31568141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isavuconazole shortens the QTc interval.
    Mellinghoff SC; Bassetti M; Dörfel D; Hagel S; Lehners N; Plis A; Schalk E; Vena A; Cornely OA
    Mycoses; 2018 Apr; 61(4):256-260. PubMed ID: 29178247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis.
    Kovanda LL; Maher R; Hope WW
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):887-97. PubMed ID: 27160418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
    Marty FM; Cornely OA; Mullane KM; Ostrosky-Zeichner L; Maher RM; Croos-Dabrera R; Lu Q; Lademacher C; Oren I; Schmitt-Hoffmann AH; Giladi M; Rahav G; Perfect JR
    Mycoses; 2018 Jul; 61(7):485-497. PubMed ID: 29611227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oral isavuconazole in a patient after Roux-en-Y gastric bypass surgery.
    Knoll BM
    J Antimicrob Chemother; 2014 Dec; 69(12):3441-3. PubMed ID: 25114167
    [No Abstract]   [Full Text] [Related]  

  • 12. Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib.
    Cummins KC; Cheng MP; Kubiak DW; Davids MS; Marty FM; Issa NC
    Leuk Lymphoma; 2019 Feb; 60(2):527-530. PubMed ID: 30037292
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of Isavuconazole serum concentrations after enteral feeding tube administration in a hospitalized cohort: A case series.
    Spivey J; Wrenn R; Liu B; Maziarz E; Kram B
    J Clin Pharm Ther; 2021 Apr; 46(2):528-531. PubMed ID: 33247433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy.
    Furfaro E; Signori A; Di Grazia C; Dominietto A; Raiola AM; Aquino S; Ghiggi C; Ghiso A; Ungaro R; Angelucci E; Viscoli C; Mikulska M
    J Antimicrob Chemother; 2019 Aug; 74(8):2341-2346. PubMed ID: 31119272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isavuconazole for treatment of rare invasive fungal diseases.
    Cornely OA; Mullane KM; Ostrosky-Zeichner L; Maher RM; Croos-Dabrera R; Lu Q; Lademacher C; Perfect JR; Oren I; Schmitt-Hoffmann AH; Giladi M; Marty FM; Rahav G
    Mycoses; 2018 Aug; 61(8):518-533. PubMed ID: 29611246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
    Ledoux MP; Denis J; Nivoix Y; Herbrecht R
    J Mycol Med; 2018 Mar; 28(1):15-22. PubMed ID: 29551442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isavuconazole to prevent invasive fungal infection in immunocompromised adults: Initial experience at an academic medical centre.
    Bowen CD; Tallman GB; Hakki M; Lewis Ⅱ JS
    Mycoses; 2019 Aug; 62(8):665-672. PubMed ID: 31050373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isavuconazole as prophylaxis and therapy for invasive fungal diseases: a real-life observational study.
    Ergün M; Jansen AME; Hilbrands LB; de Kort E; Kunst H; Reijers MHE; Schouten JA; Verweij PE; Brüggemann RJM
    J Antimicrob Chemother; 2024 Aug; 79(8):1801-1810. PubMed ID: 38935893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
    Kohno S; Izumikawa K; Takazono T; Miyazaki T; Yoshida M; Kamei K; Ogawa K; Taniguchi S; Akashi K; Tateda K; Mukae H; Miyazaki Y; Okada F; Kanda Y; Kakeya H; Suzuki J; Kimura SI; Kishida M; Matsuda M; Niki Y
    J Infect Chemother; 2023 Feb; 29(2):163-170. PubMed ID: 36307059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current therapeutic options in invasive mycosis and potential therapeutic role of isavuconazole].
    Garcia-Vidal C
    Rev Iberoam Micol; 2018; 35(4):192-197. PubMed ID: 30455108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.